CURRENT THERAPY OF CASTRATION RESISTANT PROSTATE CANCER
Mohamed Samir Sayed Hamouda;
Abstract
Prostate cancer (PCa) is the most common non cutaneous cancer in men in the US, and the second leading cause of male cancer mortality. There have been many efforts to detect this malignancy in an early curable stage and reduce its mortality rate; almost
Other data
| Title | CURRENT THERAPY OF CASTRATION RESISTANT PROSTATE CANCER | Other Titles | العلاج الحالي لسرطان البروستاتا مابعد الأخصاء | Authors | Mohamed Samir Sayed Hamouda | Keywords | CURRENT THERAPY OF CASTRATION RESISTANT PROSTATE CANCER | Issue Date | 2013 | Description | Prostate cancer (PCa) is the most common non cutaneous cancer in men in the US, and the second leading cause of male cancer mortality. There have been many efforts to detect this malignancy in an early curable stage and reduce its mortality rate; almost |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 115219G1799.pdf | 319.41 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.